Get latest articles and stories on India at LatestLY. Bharat Biotech International Ltd (BBIL) on Tuesday said its COVID-19 vaccine, Covaxin, has received emergency use approval in children 6-12 years of age in India. India News | Bharat Biotech s Covaxin Gets Emergency Approval for 6-12 Age Group.